These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Staphylococcus aureus nasal carriage and infection in patients on continuous ambulatory peritoneal dialysis. Luzar MA; Coles GA; Faller B; Slingeneyer A; Dah GD; Briat C; Wone C; Knefati Y; Kessler M; Peluso F N Engl J Med; 1990 Feb; 322(8):505-9. PubMed ID: 2300122 [TBL] [Abstract][Full Text] [Related]
6. Effect of mupirocin treatment on nasal, pharyngeal, and perineal carriage of Staphylococcus aureus in healthy adults. Wertheim HF; Verveer J; Boelens HA; van Belkum A; Verbrugh HA; Vos MC Antimicrob Agents Chemother; 2005 Apr; 49(4):1465-7. PubMed ID: 15793127 [TBL] [Abstract][Full Text] [Related]
7. Nasal carriage of meticillin resistant Staphylococcus aureus: the prevalence, patients at risk and the effect of elimination on outcomes among outclinic haemodialysis patients. Lederer SR; Riedelsdorf G; Schiffl H Eur J Med Res; 2007 Jul; 12(7):284-8. PubMed ID: 17933699 [TBL] [Abstract][Full Text] [Related]
8. Nasal carriage of Staphylococcus aureus in families of children on peritoneal dialysis. European Pediatric Peritoneal Dialysis Study Group (EPPS). Oh J; von Baum H; Klaus G; Schaefer F Adv Perit Dial; 2000; 16():324-7. PubMed ID: 11045321 [TBL] [Abstract][Full Text] [Related]
9. Oral rifampin for prevention of S. aureus carriage-related infections in patients with renal failure--a meta-analysis of randomized controlled trials. Falagas ME; Fragoulis KN; Bliziotis IA Nephrol Dial Transplant; 2006 Sep; 21(9):2536-42. PubMed ID: 16705024 [TBL] [Abstract][Full Text] [Related]
11. [Use of nasal mupirocin for Staphylococcus aureus: effect on nasal carriers and nosocomial infections]. García AM; Villa MV; Escudero ME; Gómez P; Vélez MM; Múnera MI; Franco G Biomedica; 2003 Jun; 23(2):173-9. PubMed ID: 12872556 [TBL] [Abstract][Full Text] [Related]
12. Nasal mupirocin ointment decreases the incidence of Staphylococcus aureus bacteraemias in haemodialysis patients. Boelaert JR; Van Landuyt HW; Godard CA; Daneels RF; Schurgers ML; Matthys EG; De Baere YA; Gheyle DW; Gordts BZ; Herwaldt LA Nephrol Dial Transplant; 1993; 8(3):235-9. PubMed ID: 8385291 [TBL] [Abstract][Full Text] [Related]
13. Epidemiology and prevention of Staphylococcus aureus nasal carriage in hemodialyzed patients. Souly K; Ait el kadi M; Lahmadi K; Biougnach H; Boughaidi A; Zouhdi M; Benasila S; Elyoussefi Z; Bouattar T; Zbiti N; Skalli Z; Rhou H; Ouzeddoun N; Bayahia R; Benamar L Med Mal Infect; 2011 Sep; 41(9):469-74. PubMed ID: 21752563 [TBL] [Abstract][Full Text] [Related]
14. Relative frequency of Staphylococcal carriage and antibiotic sensitivity of isolated Staphylococci in hemodialysis patients in Shiraz, Iran. Motamedifar M; Hassanzadeh P; Ghafari N Med Princ Pract; 2010; 19(5):379-83. PubMed ID: 20639662 [TBL] [Abstract][Full Text] [Related]
15. Treatment of Staphylococcus aureus colonization and prophylaxis for infection with topical intranasal mupirocin: an evidence-based review. Laupland KB; Conly JM Clin Infect Dis; 2003 Oct; 37(7):933-8. PubMed ID: 13130405 [TBL] [Abstract][Full Text] [Related]
16. Staphylococcus aureus infection in haemodialysis patients. Mupirocin as a topical strategy against nasal carriage: a review. Boelaert JR J Chemother; 1994 Apr; 6 Suppl 2():19-24. PubMed ID: 7799051 [TBL] [Abstract][Full Text] [Related]
17. Staphylococcus aureus infections in haemodialysis patients: pathophysiology and use of nasal mupirocin for prevention. Boelaert JR; Van Landuyt HW; De Baere YA; Deruyter MM; Daneels RF; Schurgers ML; Matthys EG; Gordts BZ J Chemother; 1995 Jul; 7 Suppl 3():49-53. PubMed ID: 8609538 [TBL] [Abstract][Full Text] [Related]
18. Nasal carriage as a source of Staphylococcus aureus bacteremia. Study Group. von Eiff C; Becker K; Machka K; Stammer H; Peters G N Engl J Med; 2001 Jan; 344(1):11-6. PubMed ID: 11136954 [TBL] [Abstract][Full Text] [Related]
19. Distribution of virulence genes of Staphylococcus aureus isolated from stable nasal carriers. Nashev D; Toshkova K; Salasia SI; Hassan AA; Lämmler C; Zschöck M FEMS Microbiol Lett; 2004 Apr; 233(1):45-52. PubMed ID: 15043868 [TBL] [Abstract][Full Text] [Related]